Giltuss Bucalsep Spray
Product Images NDC 65852-015

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Giltuss Bucalsep (NDC 65852-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dextrum Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Active Ingredients (Drug Facts)

Active Ingredients (Drug Facts)
Drug Facts panel showing active ingredients and purposes for Giltuss Bucalsep spray: Benzocaine 6.5% (anesthetic), Menthol 0.1% (anesthetic), and Zinc chloride 0.12% (astringent). It lists uses for temporary relief of mouth and gum irritation including sore mouth, throat, canker sores, minor dental procedures, and dentures or orthodontic appliances. Warnings advise against use in or near eyes, and limiting use to 7 days unless directed by a doctor or dentist.*
FDA Label Image

Allergy Alert (Drug Fact 1)

Allergy Alert (Drug Fact 1)
Drug Facts panel continuation for Giltuss Bucalsep spray includes a Methemoglobinemia warning describing symptoms requiring medical attention, an allergy alert regarding anesthetic allergies, do not use instructions for teething, children under 2, and prolonged use, and safety instructions on usage and when to stop and consult a doctor.*
FDA Label Image

Stop Use And Ask (Drug Facts 2)

Stop Use And Ask (Drug Facts 2)
Drug Facts panel continuation for Giltuss Bucalsep spray, listing warnings about symptoms duration, irritation, and allergic reactions. It includes instructions for use by adults and children 2 years and older, dosing frequency, and supervision advice for children under 12. Storage at room temperature and inactive ingredients such as cetylpyridinium chloride, glycerin, methylparaben, propylene glycol, propylparaben, purified water, spearmint flavor, and sucralose are noted. Contact information for questions or comments is provided.*
FDA Label Image

Indication An User (Giltuss Bucalsep Indication And Usage Section)

Indication An User (Giltuss Bucalsep Indication And Usage Section)
Drug Facts panel of Giltuss Bucalsep oral spray. Lists active ingredients benzocaine 6.5%, menthol 0.1%, and zinc chloride 0.12%, with their purposes as anesthetic and astringent. Provides uses for pain relief from mouth and gum irritations including sore mouth, canker sores, minor dental procedures, and dentures/orthodontic appliances. Includes warnings about avoiding contact with eyes and usage duration limits.*
FDA Label Image

Active Ingredients (Principal Panel)

Active Ingredients (Principal Panel)
Giltuss Bucalsep oral spray packaging label with a green background. It highlights that the product is alcohol-free, sugar-free, and dye-free, and features a new pump design. The label indicates the product is for sore throat, oral anesthetic, and oral astringent use, with text in English and Spanish. The size is 1 fluid ounce (30 mL) and it is spearmint flavored.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.